New cancer clinical trial: Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Published on: January 30, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share